Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 3 | 2026 | 958 | 0.430 |
Why?
|
| Urinary Bladder Neoplasms | 6 | 2012 | 109 | 0.400 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2012 | 39 | 0.350 |
Why?
|
| Gastric Bypass | 1 | 2012 | 69 | 0.340 |
Why?
|
| Obesity, Morbid | 1 | 2012 | 94 | 0.330 |
Why?
|
| New Hampshire | 9 | 2012 | 43 | 0.320 |
Why?
|
| Mandibular Advancement | 1 | 2007 | 1 | 0.250 |
Why?
|
| Maxilla | 1 | 2007 | 4 | 0.250 |
Why?
|
| Pharynx | 1 | 2007 | 25 | 0.250 |
Why?
|
| Molar, Third | 1 | 2006 | 1 | 0.240 |
Why?
|
| Tooth, Impacted | 1 | 2006 | 1 | 0.240 |
Why?
|
| Tooth Extraction | 1 | 2006 | 3 | 0.240 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 2025 | 8 | 0.240 |
Why?
|
| Sutures | 1 | 2006 | 40 | 0.240 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2007 | 61 | 0.230 |
Why?
|
| Incidence | 8 | 2025 | 1432 | 0.230 |
Why?
|
| Lymphoma | 1 | 2025 | 101 | 0.220 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2026 | 175 | 0.210 |
Why?
|
| Adult | 17 | 2026 | 17507 | 0.200 |
Why?
|
| Liver Neoplasms | 1 | 2026 | 308 | 0.200 |
Why?
|
| Neoplasms | 3 | 2025 | 1376 | 0.180 |
Why?
|
| Middle Aged | 16 | 2026 | 18431 | 0.180 |
Why?
|
| Environmental Monitoring | 2 | 2012 | 155 | 0.160 |
Why?
|
| Registries | 3 | 2025 | 933 | 0.160 |
Why?
|
| Aged | 14 | 2026 | 15084 | 0.150 |
Why?
|
| Male | 15 | 2026 | 31281 | 0.150 |
Why?
|
| Female | 16 | 2026 | 34294 | 0.140 |
Why?
|
| Occupational Diseases | 2 | 2010 | 266 | 0.140 |
Why?
|
| Melanoma | 2 | 2011 | 334 | 0.140 |
Why?
|
| Smoking | 3 | 2012 | 863 | 0.130 |
Why?
|
| Skin Neoplasms | 2 | 2011 | 410 | 0.120 |
Why?
|
| Risk Factors | 4 | 2026 | 5466 | 0.110 |
Why?
|
| Humans | 19 | 2026 | 65632 | 0.110 |
Why?
|
| Young Adult | 7 | 2025 | 4855 | 0.110 |
Why?
|
| Age Distribution | 2 | 2012 | 262 | 0.110 |
Why?
|
| Adolescent | 7 | 2025 | 6348 | 0.100 |
Why?
|
| Industry | 2 | 2010 | 59 | 0.100 |
Why?
|
| Occupations | 2 | 2010 | 52 | 0.100 |
Why?
|
| Neoplasm Staging | 2 | 2012 | 552 | 0.100 |
Why?
|
| Environmental Exposure | 2 | 2011 | 226 | 0.090 |
Why?
|
| Vehicle Emissions | 1 | 2012 | 23 | 0.090 |
Why?
|
| Ibuprofen | 1 | 2012 | 17 | 0.090 |
Why?
|
| Occupational Exposure | 2 | 2012 | 322 | 0.090 |
Why?
|
| Data Collection | 2 | 2010 | 384 | 0.090 |
Why?
|
| Air Pollutants, Occupational | 1 | 2012 | 75 | 0.090 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2012 | 45 | 0.090 |
Why?
|
| Dental Care | 1 | 2011 | 7 | 0.090 |
Why?
|
| Tooth Diseases | 1 | 2011 | 5 | 0.090 |
Why?
|
| United States | 5 | 2026 | 8165 | 0.090 |
Why?
|
| Case-Control Studies | 5 | 2012 | 1144 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2012 | 252 | 0.090 |
Why?
|
| Arsenic | 1 | 2011 | 14 | 0.080 |
Why?
|
| Drinking Water | 1 | 2011 | 21 | 0.080 |
Why?
|
| Water Pollutants, Chemical | 1 | 2011 | 43 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 202 | 0.080 |
Why?
|
| Ultraviolet Rays | 1 | 2011 | 153 | 0.080 |
Why?
|
| Patient Admission | 1 | 2011 | 200 | 0.080 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 325 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2010 | 210 | 0.070 |
Why?
|
| Residence Characteristics | 1 | 2010 | 230 | 0.070 |
Why?
|
| Mammography | 1 | 2010 | 294 | 0.060 |
Why?
|
| Research Design | 1 | 2010 | 590 | 0.060 |
Why?
|
| Palate, Soft | 1 | 2007 | 3 | 0.060 |
Why?
|
| Osteotomy, Le Fort | 1 | 2007 | 2 | 0.060 |
Why?
|
| Hyoid Bone | 1 | 2007 | 3 | 0.060 |
Why?
|
| Palate, Hard | 1 | 2007 | 4 | 0.060 |
Why?
|
| Tomography, Spiral Computed | 1 | 2007 | 22 | 0.060 |
Why?
|
| Osteotomy | 1 | 2007 | 20 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2012 | 5653 | 0.060 |
Why?
|
| Maine | 3 | 2011 | 18 | 0.060 |
Why?
|
| Vermont | 3 | 2011 | 15 | 0.060 |
Why?
|
| Polysomnography | 1 | 2007 | 60 | 0.060 |
Why?
|
| Dry Socket | 1 | 2006 | 1 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2010 | 468 | 0.060 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2025 | 54 | 0.060 |
Why?
|
| Oxygen | 1 | 2007 | 321 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 300 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2010 | 603 | 0.050 |
Why?
|
| Mass Screening | 1 | 2010 | 700 | 0.050 |
Why?
|
| Child | 3 | 2025 | 4632 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2011 | 1163 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 703 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2012 | 6946 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 2496 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 1233 | 0.040 |
Why?
|
| New England | 2 | 2012 | 271 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2025 | 2074 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2025 | 2639 | 0.040 |
Why?
|
| Sex Factors | 2 | 2011 | 995 | 0.030 |
Why?
|
| Age Factors | 2 | 2011 | 1592 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2006 | 5818 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2011 | 2113 | 0.020 |
Why?
|
| Time Factors | 2 | 2010 | 3776 | 0.020 |
Why?
|
| Expert Testimony | 1 | 2012 | 28 | 0.020 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2012 | 22 | 0.020 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2011 | 2 | 0.020 |
Why?
|
| Sunlight | 1 | 2011 | 28 | 0.020 |
Why?
|
| Hospitals, Private | 1 | 2011 | 8 | 0.020 |
Why?
|
| Hair Dyes | 1 | 2011 | 5 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2011 | 38 | 0.020 |
Why?
|
| Hospitals, General | 1 | 2011 | 18 | 0.020 |
Why?
|
| SEER Program | 1 | 2011 | 75 | 0.020 |
Why?
|
| Health Services Misuse | 1 | 2011 | 21 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2011 | 130 | 0.020 |
Why?
|
| Epidemiological Monitoring | 1 | 2011 | 32 | 0.020 |
Why?
|
| Gene-Environment Interaction | 1 | 2011 | 54 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 2011 | 73 | 0.020 |
Why?
|
| Metallurgy | 1 | 2010 | 16 | 0.020 |
Why?
|
| Alleles | 1 | 2012 | 455 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 374 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2012 | 274 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 199 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2011 | 136 | 0.020 |
Why?
|
| Mortality | 1 | 2011 | 162 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 67 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2011 | 288 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 196 | 0.020 |
Why?
|
| Medical Records | 1 | 2010 | 140 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 498 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2010 | 95 | 0.020 |
Why?
|
| Quality Control | 1 | 2010 | 79 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 517 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 674 | 0.020 |
Why?
|
| Urban Population | 1 | 2010 | 201 | 0.020 |
Why?
|
| Rural Population | 1 | 2010 | 224 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 931 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2009 | 755 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 1051 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 1273 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 1437 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 1710 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 1715 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 2009 | 553 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 2788 | 0.010 |
Why?
|